yingweiwo

PCSK9

PCSK9

PCSK9 related products

Structure Cat No. Product Name CAS No. Product Description
7030B-C5 V98991 7030B-C5 370871-42-4 7030B-C5 is a PCSK9 inhibitor (IC50=1.61 μM).
AZD8233 V87653 AZD8233 2604215-74-7 AZD8233 is a liver-targeting antisense oligonucleotide that inhibits proprotein convertase/subtilisin 9 (PCSK9) protein synthesis.
CVI-LM001 V87648 CVI-LM001 CVI-LM001 is a PCSK9 inhibitor that regulates the level of low-density lipoprotein cholesterol (LDL-C) in the blood by inhibiting the interaction between PCSK9 and low-density lipoprotein receptor (LDLR), thereby exerting a lipid-lowering effect.
SBC-115076 V1879 SBC-115076 489415-96-5 SBC-115076 (SBC115076) is a potent extracellular proprotein convertase subtilisin kexin type 9 (PCSK9) antagonist, with the potentialfor the treatment and/or prevention of cardiovascular diseases.
SPC4061 sodium scrambled negative control V145192 SPC4061 sodium scrambled negative control The SPC4061 sodium scrambled negative control is a negative control with the sequence of SPC4061 sodium salt scrambled.
SPC5001 sodium V87645 SPC5001 sodium SPC5001 sodium is a locked nucleic acid (LNA) modified antisense oligonucleotide (ASO) complementary to human PCSK9 (proprotein convertase subtilisin/kexin type 9) mRNA.
SPC5001 sodium scrambled negative control V145193 SPC5001 sodium scrambled negative control The SPC5001 sodium scrambled negative control is a negative control with the sequence of SPC5001 sodium salt scrambled.
SS(no Galnac)-Inclisiran sodium V145264 SS(no Galnac)-Inclisiran sodium SS(no Galnac)-Inclisiran sodium is a single-chain inclisiran that does not contain GalNAc.
SS-Inclisiran sodium V145269 SS-Inclisiran sodium SS-Inclisiran sodium is a mitotic chain of Inclisiran.
Contact Us